EVO
EVO
EVO
Live Support
Dr. Olivia Levine is a physician scientist specializing in neuroscience and psychiatry. Her expertise spans from translational neuroscience to genetics and molecular biology. She earned her MD from the Sackler School of Medicine at Tel Aviv University and her PhD in Neuroscience from Weill Cornell Medicine, where she investigated the neural circuitry of addiction and mood disorders.
She is currently completing her psychiatry residency in New York City.
Dr. Levine’s work bridges the gap between molecular neuroscience and precision psychiatry, with a focus on how hormones, genetics, and cellular metabolism interact to shape cognition and mental health.
Beyond clinical training and research, Dr. Levine is in the process of launching her own venture, which will include novel therapeutics, expert consulting, and a future private practice focused on precision psychiatry.
Dr. Levine has provided consulting and writing services to several startups, individuals, and larger companies, and is excited to work with EvoDNA.
Areas of Specialization and Credentials
Publications and Research
Dr. Levine has published in high-impact journals including Nature Communications, Biology of Sex Differences, and Cell Reports. Her work has been featured by Technology Networks and Seisma Magazine, highlighting her interdisciplinary focus on neuroscience, behavior, and translational innovation.
Selected publications and media:
Levine et al., Nature Communications (2021): “The paraventricular thalamus provides a polysynaptic brake on limbic CRF neurons to sex-dependently blunt binge alcohol drinking and avoidance behavior in mice”
Zallar, Rivera-Irizarry, Levine et al., Nature Communications (2024): “Rapid nongenomic estrogen signaling controls alcohol drinking behavior in mice”
“Eye of the Storm: Microscopy Techniques in Contemporary Neuroscience”: Technology Networks (2019)
“Matters of Taste”: Seisma Magazine (2021)
Her ongoing research examines metallothionein and iron dysregulation in schizophrenia, as well as leading a clinical trial for adjunct therapies in patients with schizophrenia.
Education
Linkedin https://www.linkedin.com/in/olivia-levine-md-phd-29b857133/